Annual General Meeting 2026
Annual General Meeting
The Annual General Meeting of Heidelberg Pharma AG took place on Tuesday, 23 June 2026.
-
Voting results (in German only)
-
Speech for the AGM (in German only)
-
Presentation for the AGM (in German only)
-
Agenda and convening of the general meeting
-
Information pursuant to § 125 AktG and Table 3 Blocks A to F Implementing Regulation EU 2018/1212)
-
Annual report 2024/2025 incl. approved consolidated financial statements, combined management report (including the report of the Management Board on the disclosures pursuant to Sections 289a, 315a of the German Commercial Code (HGB)) and report of the supervisory board
-
Approved annual financial statements 2024/2025 and combined management report (including the report of the Management Board on the disclosures pursuant to Sections 289a, 315a of the German Commercial Code (HGB)) - in German only
-
Explanations on the resolutionless agenda item 1
-
Remuneration report for the 2024/2025 financial year including audit opinion
-
CV of the proposed Supervisory Board candidate
-
Articles of Association
-
Explanation of shareholders' rights
-
Total number of shares and voting rights at the time of convening the Annual General Meeting
Motions and nominations submitted by shareholders received by the deadline regarding the agenda for our Annual General Meeting on 23 June 2026 will be published here.
Confirmation of the counting of votes pursuant to section 129 (5) sentence 1 of the German Stock Corporation Act (AktG):
Pursuant to § 129 (5) sentence 1 AktG, the person voting may request confirmation from the company within one month after the day of the Annual General Meeting as to whether and how his/her vote was counted. Such a request may be sent by email to